Large multi-modal models (LMMs) are a type of generative artificial intelligence that are starting to be used for specific health-related purposes, including scientific R&D by pharmaceutical companies.
According to the World Health Organization (WHO), LMMs “are unique in their mimicry of human communication and ability to carry out tasks they were not explicitly programmed to perform,” and require specific ethical and risk-management